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Introduction 
For several years some obstetricians have discouraged pregnant women 
from taking aspirin as a simple analgesic (De Swiet and Fryers, 1990). 
This attitude was mainly due to the avilability of paracetamol (which 
is less likely to cause gastric irritation) as well as to studies based on 
patients taking large doses of aspirin which led to the idea that aspirin 
taken during pregnancy could lead to teratogenesis (Richards, 1969; 
Nelson and Forfar, 1971; Saxen, 1975; Zierler, 1985), prolonged gestation 
(CoIl ins and Turner, 1975; Lewis and Schulman, 1973) and labour(Collins 
and Turner, 1975; Lewis and Schulman, 1973), maternal and neonatal 
haemorrhage (Rumack et al 1981; Stuart et aI, 1982), premature closure of 
the ductus arteriosus (Arcilla et al 1969; Levin et aI, 1978) and effects on 
the pulmonary blood vessels (Levin et aI, 1978; Perkin et aI, 1980). 
The possibility that treatment with daily low doses of aspirin (60-75mg) 
markedly improves perinatal outcome in certain complications of 
pregnancy postulated to be the result of derangements in prostaglandin 
biosynthesis, has recently led to the re-examination of the possible 
adverse effects of aspirin in pregnancy as well as its efficacy. There is a 
general consensus that low-dose aspirin is both safe and effective in 
improving perinatal outcome. 
This paper mainly aims at assessing the extent of aspirin use by pregnant 
women in Malta and reasons for use, any adverse effects due to such 
therapy, its effectiveness and the role of the pharmacist in this field. 
Methodology 
Case Studies 
The birth records from January 1989 to December 1991 were viewed and 
any cases of mothers with conditions where aspirin may have been used 
were selected (N=41O). Two consultants were contacted. They were 
shown the list of patients and asked to indicate which of the patients 
were most likely to be on low-dose aspirin. The mothers' files were then 
obtained from the Medical Records section of St Luke's Hospital and the 
patients' treatment together with outcome were studied. 
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Urine Tests 
During their antenatal visits, patients sometimes hide the fact that they 
are using aspirin (Collins and Turner, 1975). 158 patients attending the 
antenatal clinic at St Luke's Hospital were therefore questioned 
regarding medication they used during their pregnancy and asked 
specifically whether they used aspirin. Their urine samples were ther 
tested with 10% ferric chloride solution to detect surreptitious use. UrinE 
samples in amber-coloured bottled or in containers which made il 
difficult to note if there was a colour change were excluded from the stud) 
(N=32). 
Surveyl 
100 patients attending the antenatal clinic at St Luke's Hospital wen 
interviewed, mainly to assess whether they used aspirin, thei 
confidence in the pharmacist's advisory role and to study the medication 
most frequently used in pregnancy (especially if these interact wit: 
aspirin therapy). 
Survey 2 
25 questionnaires were personally given to consultants, registrars an 
senior house officers at the Obstetrics and Gynaecology Department of ~ 
Luke's Hospital. 
Survey 3 
Questionnaires were personally given to 51 Maltese pharmacists an 
information was drawn from the pooled results. 
Results 
Case Studies 
Only 6 files were found to specify that the patient was on low-do 
aspirin therapy. The information gathered is shown in Table 1. 
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Table 1: Details of patients studied, complication treated with aspirin 
and outcome of therapy 
Case number 1 2 3 4 5 6 
Patient's age 29 37 31 35 27 24 
Parity 1 03 1 1 0 1 
Complica tion SLE RA PIH/ PIH/ PIH PIH 
PE IUGR IUGR 
Dose (mg) 75 75 75 75 75 
Outcome alive alive alive alive alive alive 
Gestation 38-2 35+5 33 28 39 38 
Birthweight/kg 3.170 2.800 1.900 1.050 3.340 3.300 
APGARscore 6:9 9:10 9:10 9:9 6:9 4:6:9 
Caesarian + + + + 
Blood loss normal normal normal normal <20OmI normal 
Malforma tions none oes.at. none none none none 
Key: SLE: systemic lupus erythematosus 
RA: recurrent abortion 
PIH: pregnancy-induced hypertension 
PE: pre-eclampsia 
IUGR: intra-uterine growth retardation 
Oes.at.: oesophageal atresia 
Urine Tests 
The results obtained in the iron (Ill) chloride on the patients' urine 
samples are shown in Table2, whilst Figure 1 shows the medications that 
were used in pregnancy by the 126 mothers interviewed. 
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Table 2: Results of Urine Test 
Urine Test 
N=126 
Negative Positive 
Number of mothers 
Percentage 
126 
100 
o 
o 
Used Apirin 
Yes 
1 
0.79 
No 
125 
99.21 
Figure 1: Medications used in Pregnancy by 126 mothers attending the 
Antenatal Clinic at St Luke's Hospital 
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Survey 1 
Of the 100 patients interviewed, 4% were using 75mg aspirin daily, as 
prescribed by their doctor. One of these patients experienced heart burn 
but did not attribute this to her aspirin therapy. 
The other 96% of patients claimed to have never used aspirin in any of 
their pregnancies, either because there never use aspirin usually (n==51), 
or because aspirin and medicines in general are contra-indicated in 
pregnancy (n==19 and n=34 respectively), or because they do not know how 
to swallow and so never take medicines (n=2). 4 of these patients said 
that they try to do without any medication whatsoever when they are 
pregnant. 
It is interesting to note, however, ,that one patient actually took aspirin 
at some point during her. pregnancy without knowing it (DisprinR). 
Only 26% of the patients ever asked the pharmacist for advice regarding 
the use of medications in pregnancy, mostly to allay worries regarding 
any medications they may have had to take. 
94% of the patients were taking medications during their pregnancy. 
These included most of the medications indicated in Figure 1 (except for 
progesterone, diphenoxylate and prochlorperazine maleate),· as well as 
oral rehdration salts, sore throat lozenges, diazepam, clotrimazole 
cream, miconazole and insulin. 
Survey 2 
Ofthe 19 doctors who answered the questionnaire, 94.7% (n==18) were of 
the opinion that aspirin could be useful in pregnancy. 89.5% (n=17) of 
these doctors have in fact prescribed aspirin for certain pregnant patients 
who, in their professional opinion, may have benefited from such 
therapy. 
Table 3: Conditions for which 75mg Aspirin has been prescribed by 
doctors at the Antenatal Clinic at St -Luke's Hospital 
Condition 
Severe pregnancy-induced hypertension 
Intra-uterine growth retardation 
Lupus anticoagulant (SLE) 
Recurrent abortion 
Simple analgesia 
Varicose veins 
Prophylaxis of pre-eclampsia 
Superficial phlebitis 
Premature labour contractions 
Common cold 
Depp vein thrombosis 
Renal transplant in pregnancy 
% Doctors 
63.2 
68.4 
47.4 
42.1 
5.3 
5.3 
5.3 
5.3 
5.3 
5.3 
5.3 
5.3 
Few doctors claimed that aspmn caused side effects in any of their 
patients. Gastro-intestinal irritation was the main adverse effect 
reported (41.2%, n=7) even with low-dose aspirin. There was one 
reported incident (5.3%) of a patient on 75mg aspirin daily who presented 
with haematemesis soon after starting therapy - she had no previous 
relevant history. Another side-effect reported by one doctor (5.3%) was 
thrombocytopenia in a neonate. 
84.2% (n=16) of the doctors think that the pharmacist has an important 
role in preventing adverse effects due to aspirin ingestion during 
pregnancy. 
Survey 3 
Of the 42 pharmacists who ansered the questionnaire, only 21.4% were 
aware of the new uses of aspirin in pregnancy. All the pharmacists felt 
that they should know more above the use of aspirin in pregnancy and 
would appreciate the publication of a leaflet or some other source of 
information regarding its use and potential adverse effects. 
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Discussion 
Aspirin has been prescribed by obstetricians in Malta. Although, apart 
from the neonate with oesophageal atresia in Case 1, there was no 
evidence of adverse effects in any of the case studies, these did occur 
following low-dose aspirin therapy (as indicated by the survey for 
obstetricians) . 
The 100% negative result in the ferric chloride test for salicylates in 
urine indicates that Maltese mothers are conscious of the dangers of drug-
taking during pregnancy (this was further confirmed in the patient 
interviews). Thus, although this simple and cheap test may alert the 
obstetrician to a factor that may not be disclosed by patients during their 
antenatal visits6, there is no basis for strongly recommending its 
introduction at the antenatal cliniC' of 5t Luke's Hospital. 
Aspirin was found to interact with 3 of the medications being used by the 
patients interviewed, these were antacids, metaclopramide and 
labetolol. 
Conclusions 
Maltese mothers are very keen to learn more about anything to do with 
their pregnancy. This was clearly evident whilst carrying out the 
patient interviews in the antenatal clinic waiting room, since the 
patients asked various questions which they could have easily asked a 
community pharmacist. This indicates that the set-up of the antenatal 
clinic is ideal for patient education and the availability of a pharmacist 
would ~ of great benefit for the patients. It would also be. useful to have 
other forms of patient education, such as videos, etc. in the waiting rooms 
to occupy the patients' time usefully, whilst satisfying their great urge to 
l~arn more. 
The pharmacist has an important contribution to give in reducing the 
incidence 'of adverse effects of low-dose aspirin therapy. Many patients 
(as indicated by the patient using DisprinR) do not know that certain 
preparations contain aspirin and it is important for the pharmacist to 
make the patient aware of this when dispensing the preparation. Other 
ways in which the pharmacist may prevent adverse effects is by: 
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knowing the pharmacological effects of aspirin and hence its side 
effects and the possibility of aspirin allergy 
avoiding dispensing high dose aspirin to pregnant patients 
checking the dose prescribed and advising the patient to only take 
the recommended dose 
consulting a doctor in cases where he / she thinks that aspirin 
treatment is indicated 
advising the patient to take the preparation after meals and 
dispensing better-tolerated formulations 
advising on use/misuse, side effects and possible drug interactions 
advising the patient on the benefits of low dose aspirin when this 
is prescribed and reassuring her that such therapy would have no 
side-effects on the baby if administered as recommended 
The community pharmacist is in an ideal position to monitor any 
medications (whether prescribed or not) being taken by the patient, to 
check for any drug interactions or whether these are contra-indicated in 
pregnancy. 
To be able to offer the service outlined above, the pharmacist must keep 
abreast with the latest findings and be well-informed about the new uses 
of low-dose aspirin in pregnancy. A booklet was therefore compiled, so as 
to be sent to all pharmacists in Malta and Gozo (including those who did 
not participate in the survey). 
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